NCT02159950 2023-04-27Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate CancerRoswell Park Cancer InstitutePhase 2 Completed2 enrolled 7 charts
NCT01732549 2019-11-22A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based ChemotherapyIpsenPhase 2 Terminated144 enrolled 22 charts